Showing results (31-40 of 83) with videos related to
Sort By:
Pageof 9
BMJ Case Reports|July 25, 2023
Dual pathology: paraneoplastic sarcoidosis emerging at the time of progression from smouldering to symptomatic myelomaMuzna Aquil, Hannah Giles, Richard Buka, et al.Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|May 17, 2002
Fatal post-transplant lymphoproliferative disorder following allogeneic bone marrow transplantation for aplastic anemiaZbigniew Rudzki, Larissa Werda, Beata Piatkowska-Jakubas, et al.Molecular Human Reproduction|December 7, 2002
Preimplantation genetic diagnosis for beta-thalassaemia using sequencing of single cell PCR products to detect mutations and polymorphic lociNicole D Hussey, Tenielle Davis, Jenny R Hall, et al.Virchows Archiv : an International Journal of Pathology|July 28, 2004
Generalized crystal-storing histiocytosis as a presentation of multiple myeloma: a case with a possible pro-aggregation defect in the immunoglobulin heavy chainBolesław Papla, Paweł Spólnik, Ewa Rzenno, et al.Polskie Archiwum Medycyny Wewnetrznej|January 1, 2004
[Hypopituitarism and hematological abnormalities mimicking myelodysplastic syndrome. Report of four cases]Zbigniew Rudzki, Anna Matynia, Elwira Przybylik-Mazurek, et al.The New Zealand Medical Journal|November 23, 2020
Successful use of generic direct acting antiviral medications to treat hepatitis C-a New Zealand-wide studyKristina Aluzaite, Margaret Fraser, Steve Johnson, et al.Ejhaem|January 31, 2023
Bone marrow necrosis and fat embolism syndrome in sickle cell disease during COVID-19 infection treated successfully with sequential red cell and plasma exchangeSyed Rizvi, Muhammad Khakwani, Shivan Pancham, et al.Pathology Oncology Research : POR|February 11, 2019
Low Expression and Promoter Hypermethylation of the Tumour Suppressor SLIT2, are Associated with Adverse Patient Outcomes in Diffuse Large B Cell LymphomaGhada Mohamed, Soha Talima, Lili Li, et al.Blood|April 22, 2024
Testing for t(3;8) in MYC/BCL6-rearranged large B-cell lymphoma identifies a high-risk subgroup with inferior survivalBernard D Maybury, Lisa James, Neil Phillips, et al.Blood|April 20, 2002
High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistanceSusan Branford, Zbigniew Rudzki, Sonya Walsh, et al.Pageof 9